Key result
Congenital VSD is linked to ~170% higher mortality risk vs. matched controls.
Why the study?
Does congenital ventricular septal defect reduce long-term survival in patients compared to the general population?
Cohort (n=100,496)
Yes
Does congenital ventricular septal defect reduce long-term survival in patients compared to the general population?
Answers are grounded in this paper and cite their sources.
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“This guidance is not meant to replace health care providers' clinical judgment but rather to improve the value of care by reducing practice variation and optimizing resource utilization.”
Patients with isolated congenital VSD, whether unrepaired or surgically closed, have a significantly increased long-term mortality risk compared to the general population, primarily driven by cardiac-related deaths.
AIMS: The long-term survival of patients with isolated congenital ventricular septal defect (VSD) is not well described. The aim of this study was to describe the survival of a national cohort of patients with VSD compared with the general population. METHODS AND RESULTS: Using Danish nationwide medical registries, all patients diagnosed with congenital VSD (n = 9,136) in the period 1977-2018 were included. Patients with chromosomal abnormalities and concomitant congenital cardiac malformations other than atrial septal defect were excluded. Each patient was matched by birthyear and sex with ten controls from the general Danish population. Kaplan-Meier survival function and Cox proportional hazard regression were used to compute survival and mortality risk. Median follow-up was 22 years (interquartile range: 11-37). VSD patients displayed lower survival (P<0.001) yielding a hazard ratio (HR) for mortality of 2.7 [95% confidence interval (CI): 2.4-3.0] compared with matched controls. The adjusted HR for mortality among patients with unrepaired VSD was 2.7 (95% CI: 2.4-3.0) and 2.8 (95% CI: 2.1-3.7) for patients with surgically closed VSD. Stratified by era of VSD diagnosis, the HR for mortality was 3.2 (95% CI: 2.8-3.7) for unrepaired patients diagnosed before 1990 and 2.4 (95% CI: 2.0-2.7) for patients diagnosed later. Cardiac-related death was the commonest cause of death among unrepaired (30%) and surgically closed (65%) patients. CONCLUSION: Patients with VSD had lower survival compared with the general population. The HR for mortality was increased over 2.5-fold in patients with unrepaired defect (Eisenmenger syndrome excluded) and over 1.5-fold in patients with surgically closed defect (excluding surgical mortality).
Journal, society, and media accounts. Useful signal, not independent expert judgment.
No takes yet. Share an insight, caveat, or question.
Eckerström et al. (2022) conducted a cohort in Congenital ventricular septal defect (n=100,496). Congenital ventricular septal defect vs. Matched controls from the general population was evaluated on Mortality (HR 2.7, 95% CI 2.4-3.0, p=<0.001). Congenital ventricular septal defect was associated with a higher risk of mortality compared with matched controls from the general population.
Synapse has enriched 10 related papers. Consider them for comparative context: